☆ 4.6 Article

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Peripheral Vascular Disease

Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

Gianni Sesa-ashton et al.

Summary: Long-term follow-up studies on catheter-based renal denervation in patients with resistant hypertension show that the method can still effectively reduce blood pressure and decrease medication usage after nearly 9 years of follow-up, without any adverse effects on renal function.

HYPERTENSION (2023)

添加到收藏夹

Review Peripheral Vascular Disease

Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves

Kenichi Katsurada et al.

Summary: Inappropriate sympathetic activation is closely linked to hypertension. Renal denervation is an effective therapy for hypertension with significant and lasting antihypertensive effects. However, there are still issues to be addressed, such as the precise mechanisms and long-term effects of renal denervation. Comprehensive understanding of renal nerves and the antihypertensive mechanisms of renal denervation will improve its clinical application.

HYPERTENSION RESEARCH (2023)

添加到收藏夹

Review Peripheral Vascular Disease

Renal denervation: basic and clinical evidence

Kenichi Katsurada et al.

Summary: Renal nerves play a critical role in regulating blood pressure and fluid volume, with dysfunction implicated in cardiovascular diseases. Afferent renal sensory nerves project to the hypothalamus to modulate sympathetic outflow, while efferent renal sympathetic nerves affect renin secretion and vascular resistance. Studies on renal denervation show promise for treating hypertension and heart failure in both basic and clinical research settings.

HYPERTENSION RESEARCH (2022)

添加到收藏夹

Article Peripheral Vascular Disease

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study

Manish Saxena et al.

Summary: This post-hoc analysis of the RADIANCE-HTN SOLO study found that predictors of response to renal denervation (RDN) included higher baseline daytime ambulatory diastolic blood pressure and use of antihypertensive medications, with orthostatic hypertension potentially predicting response. Obese females also appeared to have a better response to RDN in an interaction model.

JOURNAL OF HUMAN HYPERTENSION (2022)

添加到收藏夹

Article Medicine, General & Internal

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud et al.

Summary: In this study, the long-term safety and efficacy of renal denervation were evaluated. The results showed that renal denervation produced a clinically meaningful and lasting blood pressure reduction up to 36 months, independent of concomitant antihypertensive medications and without major safety events.

LANCET (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range

Felix Mahfoud et al.

Summary: This study aimed to evaluate the impact of radiofrequency renal denervation (RDN) on time in therapeutic range (TTR) and its association with cardiovascular outcomes. The results showed sustained blood pressure reductions and higher TTR through 36 months after RDN. A 10% increase in TTR through 6 months was associated with significant risk reductions in major cardiovascular events from 6 to 36 months.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt et al.

Summary: The 36-month follow-up of the SYMPLICITY HTN-3 trial demonstrates the long-term safety and efficacy of renal artery denervation in patients with treatment-resistant hypertension. Patients who received renal artery denervation showed significant reductions in blood pressure and better blood pressure control compared to those who received sham control.

LANCET (2022)

添加到收藏夹

Article Peripheral Vascular Disease

Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV-Risk Study

Marit D. Solbu et al.

Summary: Data indicate that renal denervation (RDN) is safe for renal function in patients with treatment-resistant hypertension (TRHT). Evaluating kidney damage markers and long-term follow-up after RDN are crucial for monitoring kidney health.

JOURNAL OF CLINICAL HYPERTENSION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant Hypertension

Karl Fengler et al.

Summary: Observational data indicates that blood pressure response to renal sympathetic denervation is associated with improved long-term clinical outcomes. The study found that patients who responded to the treatment had significantly fewer major adverse cardiovascular events during a median follow-up period of 48 months compared to non-responders.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi et al.

Summary: Renal denervation through ultrasound treatment shows promising results in reducing blood pressure for patients with resistant hypertension, with greater effectiveness compared to a sham procedure within 2 months and similar safety outcomes. This may provide an alternative approach for patients with resistant hypertension to avoid adding more antihypertensive medications.

LANCET (2021)

添加到收藏夹

Review Urology & Nephrology

The global epidemiology of hypertension

Katherine T. Mills et al.

NATURE REVIEWS NEPHROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Bohm et al.

LANCET (2020)

添加到收藏夹

Article Peripheral Vascular Disease

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Thomas Unger et al.

HYPERTENSION (2020)

添加到收藏夹

Article Peripheral Vascular Disease

Clinical benefits and safety of renal denervation in severe arterial hypertension: A long-term follow-up study

Tino Naduvathumuriyil et al.

JOURNAL OF CLINICAL HYPERTENSION (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry

Felix Mahfoud et al.

EUROPEAN HEART JOURNAL (2019)

添加到收藏夹

Article Peripheral Vascular Disease

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Paul K. Whelton et al.

HYPERTENSION (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation

Sebastian Volz et al.

JOURNAL OF HYPERTENSION (2018)

添加到收藏夹

Article Medicine, General & Internal

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari et al.

LANCET (2018)

添加到收藏夹

Article Medicine, General & Internal

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi et al.

LANCET (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Predictors for success in renal denervation-a single centre retrospective analysis

Alexander Reshetnik et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

Robert M. Carey et al.

HYPERTENSION (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

C. Tsioufis et al.

CLINICAL RESEARCH IN CARDIOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend et al.

LANCET (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Changes in albumin-to-creatinine ratio at 12-month follow-up in patients undergoing renal denervation

Henrique Sousa et al.

REVISTA PORTUGUESA DE CARDIOLOGIA (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials

Liping Liu et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries

Katherine T. Mills et al.

CIRCULATION (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Spironolactone in Patients with Resistant Hypertension: A Meta-analysis of Randomised Controlled Trials

Chunbin Wang et al.

HEART LUNG AND CIRCULATION (2016)

添加到收藏夹

Review Medicine, General & Internal

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Dena Ettehad et al.

LANCET (2016)

添加到收藏夹

Article Peripheral Vascular Disease

Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)

B-K Kim et al.

JOURNAL OF HUMAN HYPERTENSION (2016)

添加到收藏夹

Article Urology & Nephrology

Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients

Enayet K. Chowdhury et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

添加到收藏夹

Article Peripheral Vascular Disease

2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)

Giuseppe Mancia et al.

JOURNAL OF HYPERTENSION (2013)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Current technologies: an introduction

Joost Daemen

EUROINTERVENTION (2013)

添加到收藏夹

Article Urology & Nephrology

Predictors of Estimated GFR Decline in Patients with Type 2 Diabetes and Preserved Kidney Function

Giacomo Zoppini et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.